Veeva's Q3 Net Income Jumps 27% on Strong Subscription Growth

TL;DR

**Veeva's Q3 numbers are a clear buy signal, showing robust growth and profitability in a critical niche.**

AI Summary

Veeva Systems Inc. reported robust financial performance for the three and nine months ended October 31, 2025. Total revenues for the three months increased to $811.2 million, up from $699.2 million in the prior year, representing a 16.0% increase. Subscription services revenue, a key driver, grew by 17.5% to $682.5 million from $580.9 million. Net income for the quarter rose significantly to $236.2 million, compared to $185.8 million in the same period last year, a 27.1% increase. Diluted net income per share also improved to $1.40 from $1.13. For the nine-month period, total revenues reached $2.36 billion, a 16.5% increase from $2.03 billion, and net income surged to $664.7 million, up 28.2% from $518.5 million. The company's cash and cash equivalents increased to $1.66 billion from $1.12 billion at January 31, 2025, while short-term investments grew to $4.98 billion from $4.03 billion. Deferred revenue, however, decreased to $822.5 million from $1.27 billion, indicating a shift in billing patterns or contract durations. Key business changes include continued investment in R&D, with expenses rising to $191.9 million for the quarter, and strategic focus on industry cloud solutions for the global life sciences sector.

Why It Matters

Veeva's strong performance, particularly in subscription services, signals continued dominance in the specialized life sciences cloud market, which is crucial for investors looking for stable, recurring revenue streams. The significant increase in net income and cash flow demonstrates efficient operations and strong demand for its R&D and Commercial Solutions, reinforcing its competitive moat against generalist cloud providers. For employees, this growth suggests job security and potential expansion opportunities. Customers benefit from Veeva's sustained investment in R&D, leading to enhanced product capabilities and better compliance tools. The broader market sees Veeva as a bellwether for the health of the life sciences tech sector, with its results potentially influencing valuations of other niche cloud providers.

Risk Assessment

Risk Level: low — The company exhibits a low risk profile due to its strong cash position, with cash and cash equivalents at $1.66 billion and short-term investments at $4.98 billion as of October 31, 2025. Net cash provided by operating activities for the nine months ended October 31, 2025, was $1.31 billion, demonstrating significant internal cash generation. While deferred revenue decreased, the overall financial health and consistent revenue growth mitigate immediate concerns.

Analyst Insight

Investors should consider increasing their position in VEEV, given the strong financial performance, consistent growth in subscription services, and robust cash generation. The company's dominant position in the life sciences cloud market provides a durable competitive advantage.

Financial Highlights

debt To Equity

N/A

revenue

$811.2M

operating Margin

29.7%

total Assets

$8.10B

total Debt

$1.06B

net Income

$236.2M

eps

$1.40

gross Margin

75.4%

cash Position

$1.66B

revenue Growth

+16.0%

Revenue Breakdown

Key Numbers

• $811.2M — Total Revenues (Q3 2025) (Increased 16.0% from $699.2M in Q3 2024)
• $682.5M — Subscription Services Revenue (Q3 2025) (Increased 17.5% from $580.9M in Q3 2024)
• $236.2M — Net Income (Q3 2025) (Increased 27.1% from $185.8M in Q3 2024)
• $1.40 — Diluted EPS (Q3 2025) (Increased from $1.13 in Q3 2024)
• $2.36B — Total Revenues (9 Months 2025) (Increased 16.5% from $2.03B in 9 Months 2024)
• $664.7M — Net Income (9 Months 2025) (Increased 28.2% from $518.5M in 9 Months 2024)
• $1.66B — Cash and Cash Equivalents (As of October 31, 2025, up from $1.12B at Jan 31, 2025)
• $4.98B — Short-term Investments (As of October 31, 2025, up from $4.03B at Jan 31, 2025)
• $1.31B — Net Cash from Operating Activities (9 Months 2025) (Up from $1.02B in 9 Months 2024)
• $822.5M — Deferred Revenue (As of October 31, 2025, down from $1.27B at Jan 31, 2025)

Key Players & Entities

• Veeva Systems Inc. (company) — Registrant and leading provider of industry cloud solutions for the global life sciences industry
• $811.2 million (dollar_amount) — Total revenues for the three months ended October 31, 2025
• $699.2 million (dollar_amount) — Total revenues for the three months ended October 31, 2024
• $682.5 million (dollar_amount) — Subscription services revenue for the three months ended October 31, 2025
• $580.9 million (dollar_amount) — Subscription services revenue for the three months ended October 31, 2024
• $236.2 million (dollar_amount) — Net income for the three months ended October 31, 2025
• $185.8 million (dollar_amount) — Net income for the three months ended October 31, 2024
• $1.40 (dollar_amount) — Diluted net income per share for the three months ended October 31, 2025
• $1.13 (dollar_amount) — Diluted net income per share for the three months ended October 31, 2024
• $1.66 billion (dollar_amount) — Cash and cash equivalents as of October 31, 2025

FAQ

Risk Factors

• Reliance on Key Personnel [medium — operational]: The company's success depends on its ability to attract and retain highly qualified personnel, particularly in technical and sales roles. A failure to do so could impede product development and customer acquisition.
• Intense Competition [medium — market]: The software industry, particularly in the life sciences sector, is highly competitive. New entrants and existing competitors could introduce products or services that reduce demand for Veeva's offerings.
• Data Privacy and Security [high — regulatory]: As a provider of cloud-based solutions handling sensitive customer data, Veeva is subject to stringent data privacy regulations (e.g., GDPR, CCPA). Breaches or non-compliance could result in significant fines and reputational damage.
• Deferred Revenue Fluctuation [low — financial]: The decrease in deferred revenue from $1.27B to $822.5M suggests potential shifts in billing cycles or contract terms. While not inherently negative, significant volatility could impact short-term cash flow predictability.
• Product Development and Innovation [medium — operational]: Veeva must continuously invest in research and development ($191.9M in Q3 2025) to maintain its competitive edge and meet evolving customer needs in the life sciences industry. Failure to innovate could lead to market share erosion.

Industry Context

Veeva Systems operates in the highly specialized life sciences cloud software market. The industry is characterized by stringent regulatory requirements, a need for data integrity, and a trend towards digital transformation. Competitors range from large enterprise software providers to niche players, all vying for market share by offering solutions that streamline R&D, clinical trials, regulatory affairs, and commercial operations.

Regulatory Implications

Veeva's cloud-based solutions handle sensitive patient and clinical trial data, making it subject to global data privacy regulations like GDPR and HIPAA. Compliance is paramount, as any breaches or failures to adhere to these regulations could lead to severe penalties, reputational damage, and loss of customer trust.

What Investors Should Do

1. Monitor deferred revenue trends
2. Evaluate R&D investment effectiveness
3. Assess customer retention and expansion

Key Dates

• 2025-10-31: End of Third Quarter 2025 — Reporting period for the strong financial results, showing significant revenue and net income growth.
• 2025-01-31: End of Fiscal Year 2025 — Baseline for comparison of cash and short-term investments, which have shown substantial increases.

Glossary

Deferred Revenue

Revenue that has been received by the company but not yet earned, typically because the service or product has not yet been delivered. (A decrease in deferred revenue can indicate changes in billing practices or contract lengths, impacting future recognized revenue.)

Subscription Services Revenue

Revenue generated from recurring fees for access to software and services on a subscription basis. (This is Veeva's primary revenue stream and a key indicator of business health and growth.)

Operating Income

Profitability from a company's core business operations before accounting for interest and taxes. (Shows the efficiency of the company's operations and its ability to generate profit from its primary activities.)

Diluted EPS

Earnings per share calculated after accounting for all dilutive potential common shares, such as stock options and convertible securities. (Provides a more conservative measure of profitability on a per-share basis.)

Unbilled Accounts Receivable

Revenue that has been earned but not yet invoiced to the customer. (Can indicate the timing of invoicing relative to service delivery and impacts working capital.)

Year-Over-Year Comparison

Veeva Systems Inc. demonstrated strong year-over-year performance. Total revenues for the three months ended October 31, 2025, increased by 16.0% to $811.2 million, driven by a 17.5% rise in subscription services revenue. Net income saw a significant jump of 27.1% to $236.2 million. The company's balance sheet reflects a robust increase in cash and short-term investments, up to $1.66 billion and $4.98 billion respectively, while deferred revenue saw a notable decrease from $1.27 billion to $822.5 million.

Key Financial Figures

• $0.00001 — stered Class A Common Stock, par value $0.00001 per share VEEV The New York Stock Excha

Filing Documents

• veev-20251031.htm (10-Q) — 1638KB
• veev-20251031xexx311.htm (EX-31.1) — 8KB
• veev-20251031xexx312.htm (EX-31.2) — 9KB
• veev-20251031xexx321.htm (EX-32.1) — 4KB
• veev-20251031xexx322.htm (EX-32.2) — 4KB
• veev-20251031_g1.jpg (GRAPHIC) — 17KB
• 0001393052-25-000078.txt ( ) — 7368KB
• veev-20251031.xsd (EX-101.SCH) — 36KB
• veev-20251031_cal.xml (EX-101.CAL) — 71KB
• veev-20251031_def.xml (EX-101.DEF) — 166KB
• veev-20251031_lab.xml (EX-101.LAB) — 539KB
• veev-20251031_pre.xml (EX-101.PRE) — 380KB
• veev-20251031_htm.xml (XML) — 1199KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION 4 Item 1.

Financial Statements

Financial Statements 4 Condensed Consolidated Balance Sheets 4 Condensed Consolidated Statements of Comprehensive Income 5 Condensed Consolidated Statements of Stockholders' Equity 6 Condensed Consolidated Statements of Cash Flows 7 Notes to Condensed Consolidated Financial Statements 8 Note 1. Summary of Business and Significant Accounting Policies 8 Note 2. Short-Term Investments 9 Note 3. Deferred Costs 10 Note 4. Goodwill and Intangible Assets 10 Note 5 . Fair Value Measurements 11 Note 6 . Income Taxes 12 Note 7 . Deferred Revenue, Performance Obligations, and Unbilled Accounts Receivable 13 Note 8 . Leases 13 Note 9 . Stockholders' Equity 14 Note 1 0 . Net Income per Share 15 Note 1 1 . Commitments and Contingencies 16 Note 1 2 . Segment Information 16 Note 1 3 . Information about Geographic Areas and Products 17 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 19 Overview 19 Components of Results of Operations 19 Results of Operations 22 Operating Expenses and Operating Margin 24 Non-GAAP Financial Measures 26 Liquidity and Capital Resources 28 Critical Accounting Policies and Estimates 29 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 30 Item 4.

Controls and Procedures

Controls and Procedures 31

OTHER INFORMATION

PART II. OTHER INFORMATION 32 Item 1.

Legal Proceedings

Legal Proceedings 32 Item 1A .

Risk Factors

Risk Factors 33 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 56 Item 3. Defaults Upon Senior Securities 56 Item 4. Mine Safety Disclosures 56 Item 5. Other Information 56 Item 6. Exhibits 57

SIGNATURES

SIGNATURES 58 2 Veeva Systems Inc. | Form 10-Q Table of Contents SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS This report on Form 10-Q contains forward-looking statements that are based on our beliefs and assumptions and on information currently available to us. Forward-looking statements include information concerning our possible or assumed future results of operations and expenses, business strategies and plans, trends, market sizing, competitive position, industry and macroeconomic environment, potential growth opportunities, and product capabilities among other things. Forward-looking statements include all statements that are not historical facts and, in some cases, can be identified by terms such as "aim," "anticipates," "believes," "could," "estimates," "expects," "goal," "intends," "may," "plans," "potential," "predicts," "projects," "seeks," "should," "strive," "will," "would," or similar expressions and the negatives of those terms. Forward-looking statements are based on our current views and expectations and involve known and unknown risks, uncertainties and other factors—including those described in "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," and elsewhere in this report—that may cause our actual results, performance or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Any forward-looking statements in this report are made only as of the date of this report. Except as required by law, we disclaim any obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. As used in this report, the terms "Veev

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS. VEEVA SYSTEMS INC. CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except number of shares and par value) (Unaudited) October 31, 2025 January 31, 2025 Assets Current assets: Cash and cash equivalents $ 1,660,137 $ 1,118,785 Short-term investments 4,977,164 4,031,442 Accounts receivable, net of allowance for credit losses of $ 171 and $ 57 , respectively 314,227 1,016,356 Unbilled accounts receivable 57,549 40,761 Prepaid expenses and other current assets 102,777 101,458 Total current assets 7,111,854 6,308,802 Property and equipment, net 66,117 55,912 Deferred costs, net 25,304 26,383 Lease right-of-use assets 73,839 63,863 Goodwill 439,877 439,877 Intangible assets, net 32,650 44,460 Deferred income taxes 286,966 343,919 Other long-term assets 60,544 56,540 Total assets $ 8,097,151 $ 7,339,756 Liabilities and stockholders' equity Current liabilities: Accounts payable $ 32,671 $ 30,447 Accrued compensation and benefits 41,485 39,429 Accrued expenses and other current liabilities 31,707 35,557 Income tax payable 6,020 9,024 Deferred revenue 822,466 1,273,978 Lease liabilities 10,529 9,969 Total current liabilities 944,878 1,398,404 Deferred income taxes 367 587 Long-term lease liabilities 79,267 65,806 Other long-term liabilities 32,008 42,586 Total liabilities 1,056,520 1,507,383 Commitments and contingencies ( note 11 ) Stockholders' equity: Common stock 2 2 Additional paid-in capital 2,911,418 2,386,192 Accumulated other comprehensive income (loss) 9,914 ( 8,416 ) Retained earnings 4,119,297 3,454,595 Total stockholders' equity 7,040,631 5,832,373 Total liabilities and stockholders' equity $ 8,097,151 $ 7,339,756 See Notes to Condensed Consolidated Financial Statements. 4 Veeva Systems Inc. | Form 10-Q Table of Contents VEEVA SYSTEMS INC. CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (In thousands, except per share data) (Unaudited) Three months ended Oct

View Full Filing

View this 10-Q filing on SEC EDGAR